CRMD Steven W Lefkowitz sells $475K worth of shares
Dec 13, 2025, 5:35 PM
0.00%
What does CRMD do
CorMedix is a pharmaceutical company based in New Jersey, focused on developing therapeutic products, notably DefenCath, an antimicrobial solution for preventing catheter-related bloodstream infections in kidney failure patients. The company went public in 2010 and has also sponsored research on taurolidine for rare pediatric tumors.
Steven W Lefkowitz sold 40,000 shares of CRMD on 9 December at $11.88 per share, worth a total of $475K. They now own 80,498 CRMD shares, or a 33% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.